Asymmetrical reductions of hippocampal NMDAR1 glutamate receptor mRNA in the psychoses.
about
A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depressionAerobic Exercise as a Tool to Improve Hippocampal Plasticity and Function in Humans: Practical Implications for Mental Health TreatmentStress-induced deficits in cognition and emotionality: a role of glutamateDrug models of schizophreniaActivation of 5-HT2A/C receptors counteracts 5-HT1A regulation of n-methyl-D-aspartate receptor channels in pyramidal neurons of prefrontal cortexSpatial and temporal boundaries of NMDA receptor hypofunction leading to schizophrenia.Inhibition of protein translation by the DISC1-Boymaw fusion gene from a Scottish family with major psychiatric disorders.Cannabidiol attenuates sensorimotor gating disruption and molecular changes induced by chronic antagonism of NMDA receptors in mice.Prolonged Ketamine Effects in Sp4 Hypomorphic Mice: Mimicking Phenotypes of Schizophrenia.Is lead exposure in early life an environmental risk factor for Schizophrenia? Neurobiological connections and testable hypotheses.Cross-diagnostic comparison of duration mismatch negativity and P3a in bipolar disorder and schizophrenia.Acute D-serine treatment produces antidepressant-like effects in rodentsSchizophrenia: Evidence implicating hippocampal GluN2B protein and REST epigenetics in psychosis pathophysiologyDevelopment of antipsychotic medications with novel mechanisms of action based on computational modeling of hippocampal neuropathology.Effects of the brain-derived neurotrophic growth factor val66met variation on hippocampus morphology in bipolar disorder.Antioxidant Treatment with N-acetyl Cysteine Prevents the Development of Cognitive and Social Behavioral Deficits that Result from Perinatal Ketamine TreatmentThe NMDA Receptor and Schizophrenia: From Pathophysiology to Treatment.Decreased NR1, NR2A, and SAP102 transcript expression in the hippocampus in bipolar disorder.Reviewing the ketamine model for schizophrenia.New translational assays for preclinical modelling of cognition in schizophrenia: the touchscreen testing method for mice and ratsMagnetic resonance spectroscopy studies of glutamate-related abnormalities in mood disordersAltered expression of synapse and glutamate related genes in post-mortem hippocampus of depressed subjectsThe 2nd Schizophrenia International Research Society Conference, 10-14 April 2010, Florence, Italy: summaries of oral sessions.Molecular evidence of N-methyl-D-aspartate receptor hypofunction in schizophrenia.GluN2B protein deficits in the left, but not the right, hippocampus in schizophrenia.Glutamatergic modulators: the future of treating mood disorders?NMDA receptor antagonists augment antidepressant-like effects of lithium in the mouse forced swimming test.Reduced levels of NR1 and NR2A with depression-like behavior in different brain regions in prenatally stressed juvenile offspring.Differential roles of hippocampal glutamatergic receptors in neuropathic anxiety-like behavior after partial sciatic nerve ligation in rats.Novel glutamatergic agents for major depressive disorder and bipolar disorder.Memory generalization is selectively altered in the psychosis dimensionGlutamate dysfunction in hippocampus: relevance of dentate gyrus and CA3 signaling.Cross-sectional Study of Glutamate in the Anterior Cingulate and Hippocampus in Schizophrenia.Genetic, pharmacological and lesion analyses reveal a selective role for corticohippocampal GLUN2B in a novel repeated swim stress paradigm.Semantic-episodic interactions in the neuropsychology of disbelief.Rethinking schizophrenia in the context of normal neurodevelopmentIs the modulation of retinoid and retinoid-associated signaling a future therapeutic strategy in neurological trauma and neurodegeneration?Decreased mRNA expression of netrin-G1 and netrin-G2 in the temporal lobe in schizophrenia and bipolar disorder.Targeting the glutamatergic system to develop novel, improved therapeutics for mood disordersThe role of the tripartite glutamatergic synapse in the pathophysiology and therapeutics of mood disorders.
P2860
Q24630153-D8BE9658-402A-4136-9E6F-718F1D432F7CQ26741515-4A5A05D2-8193-4D51-A02F-D9AD1832539CQ26825021-8362D06E-3B8E-44F7-8E7C-0A30704AA811Q28084198-62D3BA09-87CE-4CA1-A986-C38FFF5EDD96Q28583582-5DEFF0C6-6AB2-4651-B508-0FAD8F147751Q30355619-9FA34C8C-E482-4F1C-926C-D7B6CFF9BFC5Q30399814-80715376-07C1-4E05-856F-DA881579FA16Q30403787-886944D5-68AB-4E8D-BCFD-83E597C1066BQ30452766-5D933A52-DFD5-4BB2-A9A6-242192A80F6DQ30454141-C127D511-73D5-49E6-AEDC-020DAAA504AAQ30454920-8E3B9CDC-C192-4423-800D-3C2CDF974335Q30505292-663A6192-4B93-4C41-9A57-365A9666986AQ30982690-DC137959-27A1-4344-BEE5-D0754B716421Q31113942-332B865E-EAC0-4D52-B422-C144A986AE97Q33723741-E4AADB75-51F6-44A6-AC4C-5C1D55FBE23CQ33766147-F6FFD1AA-C184-4531-AF8D-D69F64B0EDB5Q33920257-D6C400E7-9B52-460B-BFE1-6BD1AB6650FFQ33978656-C1F9B2B3-59C0-4583-89AD-8AD26E2E51EDQ34046060-0902B7E7-9EE9-40AC-AB63-CB9BB78530F9Q34181201-63460411-BBC1-42DA-8B8C-466564A33A26Q34204211-69E9477C-0AA0-4C7F-BD90-6120BEA8427BQ34254887-0E7BE558-0F9C-4C04-A9F8-8040ED649075Q34279073-C5DCE78B-96F0-4518-805A-805EBE3CAA91Q34306261-F1C1BE22-CB37-4454-B688-0DCDCB97ED05Q34332929-4F38EA2F-0694-4C4C-A4F7-84C5665BFCDCQ34398007-4AE5E34E-394F-4E62-B06F-A12860F17F39Q34974649-D1A4F362-0763-449A-B8A2-0BEE3900F502Q35054086-D168F283-0039-42DD-9DFD-92CB26258F7BQ35213544-B6B9BFC4-7512-4183-AFC4-1A59ED9D4C27Q35661119-E9B51C32-C096-488B-9193-D0976825A622Q36002670-9B51CA0F-34B2-49E9-8CDC-17FF63C0A8A3Q36245030-4185B526-B022-4532-AAF3-86239C4A45B2Q36579976-7076BADE-36A8-4D7A-B4C2-1A748342DD88Q36700393-5FCA1D88-6783-46D9-9D97-E64FF9851437Q36799450-D22199A0-6549-45D2-AED1-04C4126902D1Q36844622-0433BF27-DF67-49B7-A940-026A90B6DA3AQ37013144-ACD936CB-5AAD-4191-BD29-F945157FCBA0Q37069416-6879312A-D776-4B00-B8C5-5259C209944FQ37143117-17FCA3F9-E560-4DEA-9150-992A779D30A1Q37387700-5F878342-9301-4F68-8DA5-20BE00A4E38A
P2860
Asymmetrical reductions of hippocampal NMDAR1 glutamate receptor mRNA in the psychoses.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Asymmetrical reductions of hippocampal NMDAR1 glutamate receptor mRNA in the psychoses.
@en
Asymmetrical reductions of hippocampal NMDAR1 glutamate receptor mRNA in the psychoses.
@nl
type
label
Asymmetrical reductions of hippocampal NMDAR1 glutamate receptor mRNA in the psychoses.
@en
Asymmetrical reductions of hippocampal NMDAR1 glutamate receptor mRNA in the psychoses.
@nl
prefLabel
Asymmetrical reductions of hippocampal NMDAR1 glutamate receptor mRNA in the psychoses.
@en
Asymmetrical reductions of hippocampal NMDAR1 glutamate receptor mRNA in the psychoses.
@nl
P1433
P1476
Asymmetrical reductions of hippocampal NMDAR1 glutamate receptor mRNA in the psychoses
@en
P2093
P304
P356
10.1097/00001756-200109170-00043
P577
2001-09-01T00:00:00Z